Cure My Disease

Don't miss your cure!

 Log in / Sign up

New way to deliver emergency meds through the breastbone tested

NCT ID NCT01853215

Knowledge-focused Sponsor: Vidacare Corporation Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a device that allows doctors to give fluids and medicines directly into the breastbone during emergencies. It involved 24 healthy adults and looked at how well the device worked and if it caused any leakage. The goal was to see if this method is a safe and reliable option when standard IV access is not possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

24 people

The number who actually took part.

Start date

Apr 2013

Finished

May 2013

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

21 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 21 years of age or older; * healthy adult subjects Exclusion Criteria: * Weight \< 45kg; * BMI greater or equal to 30 with absence of adequate landmarks or too much overlaying tissue, as determined by the PI; * Imprisoned subjects; * pregnant subjects; * prior sternotomy; * cognitively impaired subjects; * fracture in target bone, or significant trauma to the site; * excessive tissue and/or absence of adequate anatomical landmarks in target bone; * infection in target area; * IO insertion in past 48 hours or other significant orthopedic procedure in target bone; * current use of anti-coagulants; * previous adverse reaction to Lidocaine; * current cardiac condition requiring pacemaker or anti-arrhythmic drugs * previous adverse reaction to contrast dye * Allergy to any food and drug * History of impaired renal function * History of impaired hepatic function * History of cardiac disease * History of pheochromocytoma

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Intraosseous vascular access are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Intraosseous vascular access

Contacts and locations

Locations

  • Bulverde-Spring Branch EMS

    Spring Branch, Texas, 78070, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.